Windtree Therapeutics Stock Price Prediction

WINT Stock  USD 0.50  0.01  1.96%   
The RSI of Windtree Therapeutics' share price is below 30 at this time. This entails that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Windtree Therapeutics, making its price go up or down.

Oversold Vs Overbought

21

 
Oversold
 
Overbought
The successful prediction of Windtree Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Windtree Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Windtree Therapeutics' stock price prediction:
EPS Estimate Current Year
(2.38)
EPS Estimate Next Year
(2.13)
Wall Street Target Price
7
Quarterly Revenue Growth
(1.00)
Using Windtree Therapeutics hype-based prediction, you can estimate the value of Windtree Therapeutics from the perspective of Windtree Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Windtree Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Windtree because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Windtree Therapeutics after-hype prediction price

    
  USD 0.32  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Windtree Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.
Intrinsic
Valuation
LowRealHigh
0.081.6213.97
Details
1 Analysts
Consensus
LowTargetHigh
4.555.005.55
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.27-2.27-2.27
Details

Windtree Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Windtree Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Windtree Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Windtree Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Windtree Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Windtree Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Windtree Therapeutics' historical news coverage. Windtree Therapeutics' after-hype downside and upside margins for the prediction period are 0.02 and 12.67, respectively. We have considered Windtree Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.50
0.32
After-hype Price
12.67
Upside
Windtree Therapeutics is abnormally volatile at this time. Analysis and calculation of next after-hype price of Windtree Therapeutics is based on 3 months time horizon.

Windtree Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Windtree Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Windtree Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Windtree Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  3.63 
12.35
  0.18 
  0.20 
7 Events / Month
3 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.50
0.32
36.00 
24,700  
Notes

Windtree Therapeutics Hype Timeline

Windtree Therapeutics is at this time traded for 0.50. The entity has historical hype elasticity of -0.18, and average elasticity to hype of competition of -0.2. Windtree is estimated to decline in value after the next headline, with the price expected to drop to 0.32. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -36.0%, whereas the daily expected return is at this time at -3.63%. The volatility of related hype on Windtree Therapeutics is about 22870.37%, with the expected price after the next announcement by competition of 0.30. The company has Price to Book (P/B) ratio of 1.26. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Windtree Therapeutics recorded a loss per share of 19.03. The entity last dividend was issued on the 29th of April 2020. The firm had 1:18 split on the 22nd of April 2024. Given the investment horizon of 90 days the next estimated press release will be in about 7 days.
Check out Windtree Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Windtree Therapeutics Related Hype Analysis

Having access to credible news sources related to Windtree Therapeutics' direct competition is more important than ever and may enhance your ability to predict Windtree Therapeutics' future price movements. Getting to know how Windtree Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Windtree Therapeutics may potentially react to the hype associated with one of its peers.

Windtree Therapeutics Additional Predictive Modules

Most predictive techniques to examine Windtree price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Windtree using various technical indicators. When you analyze Windtree charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Windtree Therapeutics Predictive Indicators

The successful prediction of Windtree Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Windtree Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Windtree Therapeutics based on analysis of Windtree Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Windtree Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Windtree Therapeutics's related companies.
 2023 2024 (projected)
Interest Debt Per Share69.4765.99
Revenue Per Share22.7721.63

Story Coverage note for Windtree Therapeutics

The number of cover stories for Windtree Therapeutics depends on current market conditions and Windtree Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Windtree Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Windtree Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Windtree Therapeutics Short Properties

Windtree Therapeutics' future price predictability will typically decrease when Windtree Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Windtree Therapeutics often depends not only on the future outlook of the potential Windtree Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Windtree Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding220 K
Cash And Short Term Investments4.3 M

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.